| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |